Dr. Zaenglein added that hormonal therapies should be avoided within 3 years of menarche if possible.
Dr. Zaenglein is on the advisory board for Galderma, Valeant, and Promius; a speaker for Galderma; and involved in clinical trials with Galderma, Medicis, and Valeant.
On Twitter @NaseemSMiller